Wonhee So

421 total citations
18 papers, 218 citations indexed

About

Wonhee So is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Wonhee So has authored 18 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Wonhee So's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Wonhee So is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Wonhee So collaborates with scholars based in United States, Canada and Saudi Arabia. Wonhee So's co-authors include David P. Nicolau, Jared L. Crandon, Joseph L. Kuti, Shawn H. MacVane, David P. Nicolau, John N. Greene, Grace C. Lee, Cody A. Black, Gerard Gawrys and George G. Zhanel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Clinical Microbiology.

In The Last Decade

Wonhee So

17 papers receiving 213 citations

Peers

Wonhee So

PHARM

EPIDE

Paola Della Siega Italy

Luis Escosa‐García Spain

Nour Shbaklo Italy

Arta Karruli Italy

Ahmad Nusair United States

Carlo Pallotto Italy

Alicia Hernández‐Torres Spain

Jazmín Díaz-Regañón Spain

Takumi Umemura Japan

Carlos Bergallo Argentina

Paola Della Siega Italy

Wonhee So

112 ×1.2

109 ×1.2

PHARM

82 ×1.0

90 ×1.2

EPIDE

44 ×1.2

Citations per year, relative to Wonhee So Wonhee So (= 1×) peers Paola Della Siega

Countries citing papers authored by Wonhee So

Since Specialization

Citations

This map shows the geographic impact of Wonhee So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wonhee So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wonhee So more than expected).

Fields of papers citing papers by Wonhee So

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wonhee So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wonhee So. The network helps show where Wonhee So may publish in the future.

Co-authorship network of co-authors of Wonhee So

This figure shows the co-authorship network connecting the top 25 collaborators of Wonhee So. A scholar is included among the top collaborators of Wonhee So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wonhee So. Wonhee So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Black, Cody A., Steven D. Dallas, Gerard Gawrys, et al.. (2024). Diverse Role of blaCTX-M and Porins in Mediating Ertapenem Resistance among Carbapenem-Resistant Enterobacterales. Antibiotics. 13(2). 185–185. 4 indexed citations

So, Wonhee, et al.. (2022). Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports. SHILAP Revista de lepidopterología. 34(1). 58–58. 5 indexed citations

So, Wonhee, Matthew S. Simon, Justin J. Choi, et al.. (2022). Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels. Internal and Emergency Medicine. 17(5). 1405–1412. 5 indexed citations

Black, Cody A., et al.. (2021). Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas. Frontiers in Microbiology. 11. 623574–623574. 20 indexed citations

Kubin, Christine J., Angela Loo, Jennifer Cheng, et al.. (2021). Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities. American Journal of Health-System Pharmacy. 78(8). 743–750. 17 indexed citations

Hicks, J. Kevin, Rami S. Komrokji, Timothy Kubal, et al.. (2019). Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. Clinical Pharmacology & Therapeutics. 107(3). 563–570. 34 indexed citations

So, Wonhee, et al.. (2018). INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB. Mediterranean Journal of Hematology and Infectious Diseases. 10(1). 2018029–2018029. 5 indexed citations

Hicks, J. Kevin, Rami S. Komrokji, Timothy Kubal, et al.. (2018). CYP2C19-guided voriconazole prophylaxis in neutropenic AML patients.. Journal of Clinical Oncology. 36(15_suppl). 6594–6594. 1 indexed citations

So, Wonhee, et al.. (2017). Infectious Risks and Complications in Adult Acute Lymphoblastic Leukemia (ALL) Patients Receiving Blinatumomab. Open Forum Infectious Diseases. 4(suppl_1). S703–S703.

10.

So, Wonhee, et al.. (2016). Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration. American Journal of Health-System Pharmacy. 74(1). e55–e63. 3 indexed citations

11.

So, Wonhee, Jared L. Crandon, & David P. Nicolau. (2015). Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus. Internal and Emergency Medicine. 11(4). 545–551. 6 indexed citations

12.

So, Wonhee, Jared L. Crandon, Yukihiro Hamada, & David P. Nicolau. (2015). Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem. Journal of Antimicrobial Chemotherapy. 71(2). 428–437. 12 indexed citations

13.

So, Wonhee, Jared L. Crandon, & David P. Nicolau. (2015). Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae. The Journal of Urology. 194(2). 563–570. 31 indexed citations

14.

So, Wonhee, Jared L. Crandon, & David P. Nicolau. (2015). Pharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection Model. Antimicrobial Agents and Chemotherapy. 59(8). 4956–4961. 18 indexed citations

15.

So, Wonhee, Joseph L. Kuti, & David P. Nicolau. (2014). Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI). Infectious Diseases and Therapy. 3(2). 269–279. 15 indexed citations

16.

MacVane, Shawn H., Wonhee So, David P. Nicolau, & Joseph L. Kuti. (2014). In Vitro Activity of Human-Simulated Epithelial Lining Fluid Exposures of Ceftaroline, Ceftriaxone, and Vancomycin against Methicillin-Susceptible and -Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 58(12). 7520–7526. 18 indexed citations

17.

So, Wonhee, Jared L. Crandon, George G. Zhanel, & David P. Nicolau. (2014). Comparison of In Vivo and In Vitro Pharmacodynamics of a Humanized Regimen of 600 Milligrams of Ceftaroline Fosamil Every 12 Hours against Staphylococcus aureus at Initial Inocula of 10 ⁶ and 10 ⁸ CFU per Milliliter. Antimicrobial Agents and Chemotherapy. 58(11). 6931–6933. 10 indexed citations

18.

Baden, Lindsey R., Ian A. Critchley, D.F. Sahm, et al.. (2002). Molecular Characterization of Vancomycin-Resistant Enterococci Repopulating the Gastrointestinal Tract following Treatment with a Novel Glycolipodepsipeptide, Ramoplanin. Journal of Clinical Microbiology. 40(4). 1160–1163. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact